Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease

HIGHLIGHTS

• who: Hiroko Iijima from the Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hyogo Medical University, u2011, Mukogawau2011cho, Nishinomiya, Hyogo, u20118501, Japan have published the article: Utility of ultrasonography for predicting indications for tolvaptan in patients with autosomal dominant polycystic kidney disease, in the Journal: (JOURNAL)
• what: The authors investigated whether ultrasonography can be used for TKV assessment in patients with ADPKD. Although the study included fewer patients than the study by O`Neill et_al, one strength of this study is that the most appropriate ultrasound measurement (i.e., total mediolateral distance) was determined . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.